Controlling nucleation and crystal growth during reactive crystallization of monosodium urate monohydrate from simulated synovial fluid by N2 fine bubble injection

被引:5
作者
Matsumoto M. [1 ]
Wada Y. [1 ]
Otsu R. [1 ]
Kobayashi N. [1 ]
Okada M. [1 ]
机构
[1] College of Industrial Technology, Nihon University, 2-11-1 Shinei, Narashino, 275-8576, Chiba
关键词
A1. Crystal growth; A1. Fine bubbles; A1. Gas-liquid interface; A1; Nucleation; B1. Monosodium urate monohydrate;
D O I
10.1016/j.jcrysgro.2020.125622
中图分类号
学科分类号
摘要
To control the nucleation and growth of monosodium urate monohydrate (MSU) crystals, we studied the reactive crystallization of MSU from simulated synovial fluid using the gas–liquid interfaces around N2 fine bubbles as novel crystallization fields. In the regions near the gas–liquid interfaces, local supersaturation is generated because of the accumulation of Na+ resulting from the negative electric charge on the fine bubble surface. Hence, the micronization of MSU crystals is expected to occur via growth suppression through the enhancement of nucleation. N2 fine bubbles were continuously supplied to the simulated synovial fluid with 140 mmol/L-Na+ and 3.6 mmol/L-uric acid using a pressurized dissolution-type fine bubble generator. The injection time of the N2 fine bubbles was varied within 60 min to control the volume density of the fine bubbles. The simulated synovial fluid containing N2 fine bubbles was sampled and sealed on a microscope slide, and the reactive crystallization of MSU was performed by standing operation. When the volume density of fine bubbles was increased, the crystal growth was suppressed because of the increasing effective nuclei number and the decreasing consumption of supersaturation for crystal growth caused by the acceleration of nucleation, which led to the generation of numerous fine crystals of needle-shaped MSU. © 2020 Elsevier B.V.
引用
收藏
相关论文
共 34 条
[1]  
Dalbeth N., Merriman T.R., Stamp L.K., Lancet, 388, (2016)
[2]  
Martillo M.A., Nazzal L., Crittenden D.B., Curr. Rheumatol. Rep., 400, (2014)
[3]  
Roddy E., Doherty M., Arthritis Res. Ther., 12, (2010)
[4]  
Choi H.K., Mount D.B., Reginato A.M., Ann. Intern. Med., 43, (2005)
[5]  
Wu X.W., Muzny D.M., Lee C.C., Caskey C.T., J. Mol. Evol., 34, (1992)
[6]  
Dieppe P.A., Shah J., Prog. Cryst. Growth Charact., 3, (1980)
[7]  
Ozono C., Hirasawa I., Kohori F., Chem. Eng. Technol., 40, (2017)
[8]  
Allen D.J., Milosovich G., Mattocks A.M., Arthritis Rheum., 8, (1965)
[9]  
Rinaudo C., Boistelle R., J. Cryst. Growth, 57, (1982)
[10]  
Mohamed A.A., Matijevic E., J. Colloid Interface Sci., 392, (2013)